Nursing Elites

1. Which of the following is a chronic condition where the heart muscle is weakened and unable to pump blood effectively, often leading to heart failure?

• A. Dilated cardiomyopathy
• B. Hypertrophic cardiomyopathy
• C. Restrictive cardiomyopathy
• D. Myocarditis

Correct answer: A

Rationale: Dilated cardiomyopathy is characterized by the heart muscle being weakened and unable to pump blood effectively, ultimately resulting in heart failure. Choice B, Hypertrophic cardiomyopathy, involves the heart muscle becoming abnormally thick, reducing the heart's efficiency. Choice C, Restrictive cardiomyopathy, refers to the heart becoming rigid and less able to fill with blood properly. Myocarditis, as in Choice D, is inflammation of the heart muscle usually caused by a viral infection and is different from the chronic weakening seen in dilated cardiomyopathy.

2. What is the procedure where a device is used to shock the heart back into a normal rhythm during a life-threatening arrhythmia?

• A. Defibrillation
• B. Cardioversion
• C. Echocardiogram
• D. Ablation

Correct answer: A

Rationale: The correct answer is A, Defibrillation. Defibrillation is the procedure of using a device to deliver an electric shock to the heart during life-threatening arrhythmias like ventricular fibrillation or ventricular tachycardia to restore a normal rhythm. Choice B, Cardioversion, is similar but is typically used for less severe arrhythmias. Choice C, Echocardiogram, is a diagnostic test that uses sound waves to create images of the heart. Choice D, Ablation, is a procedure to treat certain types of arrhythmias by scarring or destroying tissue that triggers abnormal electrical signals.

3. What is a condition where the heart's electrical impulses are blocked or delayed, leading to a slower or irregular heartbeat?

• A. Heart block
• B. Atrial fibrillation
• C. Tachycardia
• D. Bradycardia

Correct answer: A

Rationale: Heart block is the correct answer. It is a condition where the electrical impulses in the heart are blocked or delayed, resulting in a slower or irregular heartbeat. This can lead to symptoms like dizziness, fainting, or other issues. Atrial fibrillation (B) is characterized by rapid, irregular heartbeats. Tachycardia (C) is a condition where the heart rate is too fast. Bradycardia (D) is the opposite of tachycardia, where the heart rate is too slow.

4. The client has a prescription for sublingual nitroglycerin. What is the nurse's instruction for how to take this medication during an episode of chest pain?

• A. Take one tablet every 5 minutes, up to three tablets.
• B. Take one tablet every hour until the pain subsides.
• C. Take two tablets immediately if chest pain occurs.
• D. Take one tablet with a full glass of water.

Correct answer: A

Rationale: The correct answer is A. The standard instruction for sublingual nitroglycerin during an episode of chest pain is to take one tablet every 5 minutes, up to three tablets. If the pain persists after taking three tablets, the client should seek emergency help. Choice B is incorrect because taking one tablet every hour is not the appropriate dosing for acute chest pain. Choice C is incorrect as taking two tablets immediately is not in line with the recommended dosing instructions. Choice D is incorrect because sublingual nitroglycerin should be placed under the tongue, not swallowed with water.

5. When administering enoxaparin (Lovenox) to a client, what is the most important lab value to monitor?

• A. Platelet count
• B. aPTT
• C. Hemoglobin
• D. INR

Correct answer: A

Rationale: The correct answer is A: Platelet count. When administering enoxaparin (Lovenox), it is crucial to monitor the platelet count because enoxaparin can cause a rare but serious side effect known as heparin-induced thrombocytopenia, which is a decrease in platelet count that can lead to increased risk of bleeding. Monitoring the platelet count allows for early detection of this potential complication. Choices B, C, and D are incorrect because aPTT, Hemoglobin, and INR are not the most important lab values to monitor specifically when administering enoxaparin.

Similar Questions